Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta

Feature Writer

B.Sc. Physiology, M.Sc. Physiology, Ph.D. Physiology

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world.

See more

Since she was very young, Dr. Dutta was passionate about the world of science and making it accessible to all. During her time at school, Dr. Dutta particularly enjoyed taking part in biology experiments in the laboratory. The inner workings and diversity of the human body used to surprise her every day and eventually inspired her to become a biologist.

In order to learn more about the subject, Sanchari decided to take biology as her main subject at university and gained Bachelor of Science (B.Sc.) and Master of Science (M.Sc.) degrees in human physiology from the University of Calcutta, India.

This was followed by a Ph.D., also in physiology. During her tenure (2004 – 2010), she received the ‘Surg. Rear Admiral M.S. Malhotra Research Prize’ for best publication from the Defence Institute of Physiology and Allied Sciences, India.

Her thirst for knowledge and dream to be a science writer were always abreast throughout her academic tenure. However, instead of starting her career as a writer straight away, Sanchari decided to further her knowledge of the molecular biology of the human body and carried out postdoctoral research for 6 years after her Ph.D.

During this period, Dr. Dutta received ‘Dean of Faculty fellowship of Weizmann Institute of Science, Israel’ and ‘PBC fellowship for outstanding post-doctoral researchers from China and India in Israeli universities’.

Alongside bench work, she authored more than 10 original research articles, all published in renowned international journals.

In 2016, she started working with a leading medical communication company and formally became a freelance science writer. Since then, she has engaged in writing a wide variety of scientific articles, including original research articles, review articles, science discoveries, popular science articles, and healthcare articles. Her first review article as a science writer was recently published in the journal ‘Oxidative Medicine and Cellular Longevity’.

Her work with News Medical offers a great platform for a wide range of audience to learn about the science behind good health.  

See less

Articles from Sanchari Sinha Dutta

Vesicular stomatitis virus-based COVID vaccines demonstrate potent antiviral efficacy against SARS-CoV-2 variants

Vesicular stomatitis virus-based COVID vaccines demonstrate potent antiviral efficacy against SARS-CoV-2 variants

Multiplexed electrochemical sensor platform enables simultaneous detection of SARS-CoV-2 RNA and host antibodies

Multiplexed electrochemical sensor platform enables simultaneous detection of SARS-CoV-2 RNA and host antibodies

Israeli study on viral load, Delta infections, vaccinations and boosters

Israeli study on viral load, Delta infections, vaccinations and boosters

Post-exposure prophylaxis with monoclonal antibodies may reduce health system burden in the US

Post-exposure prophylaxis with monoclonal antibodies may reduce health system burden in the US

Increased evolutionary rates seen in SARS-CoV-2 variants of concern

Increased evolutionary rates seen in SARS-CoV-2 variants of concern

Booster shot of Pfizer COVID-19 vaccine provides additional protection against SARS-CoV-2 infection

Booster shot of Pfizer COVID-19 vaccine provides additional protection against SARS-CoV-2 infection

Anti-SARS-CoV-2 immunity induced by Pfizer/BioNTech vaccine may decline after 6 months

Anti-SARS-CoV-2 immunity induced by Pfizer/BioNTech vaccine may decline after 6 months

mRNA COVID-19 vaccines induce high antibody titers with significant neutralizing potency in saliva

mRNA COVID-19 vaccines induce high antibody titers with significant neutralizing potency in saliva

Scientists identify potential biomarkers to predict COVID-19 outcomes

Scientists identify potential biomarkers to predict COVID-19 outcomes

Vaccinated individuals with breakthrough SARS-CoV-2 infection have much lower risk of hospitalization

Vaccinated individuals with breakthrough SARS-CoV-2 infection have much lower risk of hospitalization

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.